AI Insight: Zimmer Biomet appears significantly undervalued, with a current price at $88.57 against a high-confidence fair value of $281.36 and strong upside potential per DCF and Monte Carlo analyses. Financial health scores indicate fair liquidity and leverage but lower profitability, efficiency, and growth. High valuation volatility and zero downside risk below the current price signal notable opportunity with moderate operational risk.